Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
7,300.00    605.00 (9.04%)
Bid:
7,695.00
Ask:
5,695.00
Spread: -2,000.00 (-25.991%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Director/PDMR Shareholding

14 May 2026 10:39

RNS Number : 3607E
Spirax Group PLC
14 May 2026
 

 

14 May 2026

Award of Shares to Persons Discharging Management Responsibilities ("PDMRs") of Spirax Group plc (the "Company")

 

Further to the announcement made on 26 March 2026 regarding awards granted under the Company's 2023 Performance Share Plan ("2023 PSP"), the Company confirms that, following shareholder approval at the Company's 2026 Annual General Meeting of the updated Remuneration Policy and the Company's Share Award Plan Rules, (Share Rules) the following additional awards have been approved.

As disclosed in the Company's 2025 Annual Report and Accounts, Nimesh Patel, Group Chief Executive Officer, was awarded a Performance Share Plan ("PSP") award for the 2026 grant cycle in two parts.

In March 2026, an initial award equivalent to 250% of base salary was granted in accordance with the Company's existing Remuneration Policy. The remaining part of the award was subject to shareholder approval of the new Remuneration Policy and the Share Rules, which has now been obtained at the Company's 2026 Annual General Meeting on 13 May 2026.

Following that approval, the Remuneration Committee has granted the second part of Nimesh Patel's 2026 PSP award of 6,193 shares. Consistent with the disclosure in the Company's Annual Report 2025, this award has been granted using the same March 2026 grant price, and on the same performance conditions and vesting timetable as the initial March 2026 award.

Further to the disclosure in the 2025 Directors' Remuneration Report, the Company confirms that an additional award has been approved for Louisa Burdett, Group Chief Financial Officer.

An administrative error resulted in Louisa's March 2025 PSP award being calculated at 125% of her 2025 base salary, rather than the intended 175%, as disclosed in the Annual Report 2024. To correct this error, a further award in respect of the shortfall of 4,171 shares has been granted today, on the same terms and conditions as the original March 2025 PSP award.

The awards described above will vest subject to the achievement of the applicable performance conditions over the relevant performance periods and are subject to the post‑vesting holding requirements set out in the Remuneration Policy.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nimesh Patel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Spirax Group plc

b)

 

LEI

 

 

213800WFVZQMHOZP2W17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

2612/13p Ordinary Shares

Identification code

ISIN: GB00BWFGQN14

b)

 

Nature of the transaction

 

A conditional award of ordinary shares in the Company's 2023 PSP. 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£65.67

6,193

d)

 

Aggregated information

- Aggregated volume

6,193

- Aggregated Price per share

£65.67

e)

 

Date of the transaction

 

 

14 May 2026

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Louisa Burdett

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Spirax Group plc

b)

 

LEI

 

213800WFVZQMHOZP2W17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

2612/13p Ordinary Shares

Identification code

ISIN: GB00BWFGQN14

b)

 

Nature of the transaction

 

 

A conditional award of ordinary shares in the Company's 2023 PSP.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£71.92

4,171

d)

 

Aggregated information

- Aggregated volume

4,171

- Aggregated Price per share

£71.92

e)

 

Date of the transaction

 

 

14 May 2026

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKQBNCBKKOPD
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.